Anmeldung
Gruppen
Forscher/innen
Ergebnisse
SIDA E INFECCIONES VIH
Lund University
Lund, Suecia
Sie sind in
Zusammenarbeiten
Lund University
Publikationen in Zusammenarbeit mit Forschern von Lund University (2)
2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
2015
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
Kontakt
Rechtlicher Hinweis
Hilfe
translate
de
arrow_drop_down
translate
de
arrow_drop_down
es
eu
en
fr
